Wells Fargo’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-297	Closed	-$240	–	7335
2025 Q2	$240	Sell	297 -7,615	-96%	-$6.59K	﹤0.01%	6430
2025 Q1	$6.08K	Buy	7,912 +175	+2%	+$163	﹤0.01%	5991
2024 Q4	$9.87K	Buy	7,737 +1,684	+28%	+$2.23K	﹤0.01%	5939
2024 Q3	$12.5K	Buy	6,053 +261	+5%	+$1.21K	﹤0.01%	5737
2024 Q2	$22.1K	Buy	5,792 +518	+10%	+$2.11K	﹤0.01%	5557
2024 Q1	$25K	Buy	5,274 +675	+15%	+$2.63K	﹤0.01%	5511
2023 Q4	$19.6K	Buy	4,599 +963	+26%	+$2.93K	﹤0.01%	5641
2023 Q3	$11.2K	Sell	3,636 -584	-14%	-$2.19K	﹤0.01%	5777
2023 Q2	$19K	Buy	4,220 +4,042	+2,271%	+$24.2K	﹤0.01%	5757
2023 Q1	$1.01K	Sell	178 -164	-48%	-$1K	﹤0.01%	6372
2022 Q4	$2.07K	Sell	342 -29	-8%	-$186	﹤0.01%	6008
2022 Q3	$2K	Buy	371 +184	+98%	+$1.24K	﹤0.01%	6180
2022 Q2	$1K	Buy	187 +87	+87%	+$443	﹤0.01%	6578
2022 Q1	$1K	Sell	100 -3,052	-97%	-$27.9K	﹤0.01%	6845
2021 Q4	$39K	Buy	3,152 +3,109	+7,230%	+$50.6K	﹤0.01%	6079
2021 Q3	$2K	Hold	43	–	–	﹤0.01%	6587
2021 Q2	$1K	Sell	43 -972	-96%	-$34.6K	﹤0.01%	6715
2021 Q1	$44K	Sell	1,015 -3,791	-79%	-$251K	﹤0.01%	5874
2020 Q4	$344K	Buy	+4,806	New	+$239K	﹤0.01%	4793